Earnings release
Page 1
DISCOVERY LIMITED (Incorporated in the Republic of South Africa) (Registration number 1999/007789/06) Legal Entity Identifier: 378900245A26169C8132 JSE share code: DSY, DSBP DSY ISIN: ZAE000022331 DSBP ISIN: ZAE000158564 JSE bond company code: DSYI (“Discovery” or the “Group”) Operational update and trading statement for the six-month period ended 31 December 2025 1. Operational update: Strong overall performance Discovery delivered robust results for the six-month period ended 31 December 2025 (the “reporting period”): • Normalised profit from operations is expected to increase by between 22% and 27%, compared to 31 December 2024 (the “prior period”). • Headline earnings ("HE") is expected to increase by between 27% and 32%. • Normalised headline earnings ("NHE") is expected to increase by between 25% and 30%. • New business annual premium income (API) increased 12% for the reporting period. 2. Performance of operating businesses within Discovery South Africa (SA) and Vitality for the reporting period Operating business Growth in normalised profit from operations expected for the reporting period Growth in new business API Discovery Life1 13% to 18% (1%) Discovery Health 3% to 8% 16% Discovery Invest1 0% to 5% 13% Discovery Insure 32% to 37% (2%) Discovery Bank Profit increased by between R210 million to R230 million, from prior period loss of R145 million Discovery SA1 16% to 21% 10% VitalityHealth 95% to 100% 9% VitalityLife 5% to 10% 36% Ping An Health Insurance 33% to 38% 6% Vitality Network decreased by 45% to 50% Vitality Health International other losses reduced by 85% to 90% Vitality (Vitality UK & Vitality Global) 38% to 43% 16% Normalised profit from operations1 22% to 27% New business API 12% 1. Restated prior period result, as published in the Group’s full year 2025 financial statements, per section 4 3. Business specific observations The Vitality Shared -value (SV) model had a significant impact across both the SA and global composites, and within each business of each comp osite. This manifested in superio r margins for the short -term businesses , superior returns on capital for the long-term businesses and scalable growth in value for Discovery Bank. Discovery SA’s robust operating performance reflects compelling contribution s from each business within the South African composite.
Page 2
• Discovery Bank performed ahead of plan and t here was a further acceleration in the acquisition of clients, averaging approximately 1,500 customers per day by the end of the reporting period. Additionally, all key metrics performed well – the credit loss ratio, increases in non-interest revenue and net interest income – illustrating the consistent quality of customers and their levels of engagement and primacy. • Discovery Health delivered strong new business growth, with an improved risk profile expected to benefit the scheme. Earnings growth was solid, as a result of continued scalability and cost efficiency, fully absorbing a once-off administration concession to members of R125 million disclosed in December 2025. • Discovery Life ’s operating profit grew strongly, driven in part by continued favourable mortality and morbidity experience. New business grew 16% on the embedded value (EV) basis, including a recovery from group life. Total API declined slightly - a result of the impact of lower inflation rates on automatic contribution increases (ACIs) and lower umbrella fund sales, both of which are not incorporated into the EV basis. • Discovery Invest benefited from strong growth in capital markets and positive net flows. The rate of earnings growth was dampened by an in-period asset liability matching loss related to the steep decline in yields, following the prior period asset liability matching gain. Excluding this, earnings increased 21%, in line with the growth in assets. New business was robust, with API increasing 13%. • Discovery Insure delivered a strong result, with rigorous implementation of the SV model resulting in a substantial increase in operating margin – with specific focus on pricing and claims management, whilst maintaining quality of new business. The Vitality composite’s progress reflects the work done to restructure and scale the composite onto one platform based on the Vitality Shared-value model: • VitalityHealth performed ahead of plan, with a substantial increase in operating margin from the focused execution of the SV model , through rigorous pricing and claims actions, as well as effective expense managemen t. New business production was robust despite a challenging economic environment. • VitalityLife performed robustly with earnings growth reflecting the expected unwind of the Contractual Service Margin (CSM). The business successfully leverage d the SV model to deliver excellent levels of new business growth and new business value - important determinant s of return on invested capital and future earnings momentum. • Ping An Health Insurance (PAHI) delivered an excellent performance , with a strong operating result boosted by exceptional investment returns from equity markets in China . New business growth was impacted by recent changes implemented to its distribution arrangement with Ping An Life (PAL), another Ping An Group subsidiary . In response to PAL’s regulatory requirements pertaining to related parties, it ceased distributing PAHI’s main eShengBao product range , accounting for approximately 22.5% of new business at the time (September 2025). This will affect new business production in the short term but is being ameliorated by PAHI’s rapidly growing multi-channel distribution capability, and a widening product range . Existing eShengBao in-force policies that were sold by PAL will remain with PAHI and the impact on PAHI's operating profits is expected to be largely mitigated. • Vitality Network’s reported profit was significantly impacted by the decline in the Japanese Yen over the reporting period. The consistent and exceptional performance of Sumitomo Life has driven an increased Yen-based contract asset, which resulted in earnings volatility through its currency translation, as required by the applicable accounting standard. Excluding the impact of economics, primarily the significant change in the Yen/USD over the reporting period, profits increased 7%, reflecting the restructure underway to build greater longer-term scale and value. • The Group has invested into Vitality AI, and launched its partnership with Google, over the reporting period, which is anticipated to drive increased engagement in the Vitality programmes globally , accelerating traction in existing partnerships and enhancing the value from new partnerships. 4. Trading statement As published in t he Group’s full year 2025 financial statements, Discovery Life and Invest ’s earnings to 31 December 2024 were restated upwards, following a correction in the allocation between the CSM and Insurance Finance Reserve (IFR). The trading statement below incorporates the restatement of all core measures to ensure the correct comparison to the prior period.
Page 3
Shareholders and noteholders are advised that, for the reporting period : • Earnings per share ("EPS") (basic) is expected to increase by between 25% and 30% (to between 826.6 cents and 859.7 cents) compared to the restated EPS (basic) of 661.3 cents (previously reported of 637.1 cents) for the prior period. • Headline earnings per share ("HEPS") (basic) is expected to increase by between 25% and 30% (to between 833.9 cents and 867.2 cents) compared to the restated HEPS (basic) of 667.1 cents (previously reported of 642.9 cents) for the prior period. • Normalised HEPS ("NHEPS") (basic) is expected to increase by between 24% and 29% (to between 842.7 cents and 876.7 cents) compared to the restated NHEPS (basic) of 679.6 cents (previously reported of 655.4 cents) for the prior period. Further details of the above will be available when Discovery reports on its results for the six months ended 31 December 2025, expected to be released on or about 3 March 2026. The information contained in this announcement, including any forecast financial information on which this trading statement is based, is the responsibility of the board of directors of Discovery and has not been reviewed and reported on by Discovery's joint external auditors. Sandton 26 February 2026 Equity and Debt Sponsor Nedbank Corporate and Investment Banking, a division of Nedbank Limited